Stock Price
5.95
Daily Change
-0.01 -0.17%
Monthly
5.50%
Yearly
13.12%
Q2 Forecast
5.82

Ardelyx reported $5.76M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Abbott USD 68M 26M Mar/2026
Amgen USD 653M 32M Dec/2025
Ardelyx USD 5.76M 37K Dec/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Curis USD 178K 441K Dec/2023
Sanofi EUR -25M 99.78M Dec/2025
TG Therapeutics USD 6.53M 187K Dec/2025
United Therapeutics USD 3.1M 100K Dec/2025
Xoma USD 3.4M 150K Jun/2024